EDGAR Filing Documents for 0001399529-20-000018

Form 8-K - Current report:

SEC Accession No. 0001399529-20-000018

Filing Date

2020-03-31

Accepted

2020-03-31 08:10:26

Documents

Period of Report

2020-03-31

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	drna_20200331x8k.htm	8-K	29234
2	EXHIBIT 99.1	exhibit991.htm	EX-99.1	19093
3		dicernalogowithtrademarkfeb2.jpg	GRAPHIC	22788
	Complete submission text file	0001399529-20-000018.txt		80899

Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097

Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 20759684
SIC: 2834 Pharmaceutical Preparations